# \[e-drug\] Bio-Equivalence

**URL:** <https://talk.edrugplus.org/t/e-drug-bio-equivalence/15683>\
**Category:** e-drug\
**Created:** [December 12, 2002, 11:46pm UTC](https://talk.edrugplus.org/t/e-drug-bio-equivalence/15683 "2002-12-12T23:46:00Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![ahsan](https://avatars.discourse-cdn.com/v4/letter/a/958977/32.png) [@ahsan](https://talk.edrugplus.org/u/ahsan)\
**Post date:** [December 12, 2002, 11:46pm UTC](https://talk.edrugplus.org/t/e-drug-bio-equivalence/15683/1 "2002-12-12T23:46:00Z")

</div>

E-drug: Bio-Equivalence  
---------------------------------------------

Dear Colleagues!

I am interested to know if there are any pre-requisites of  
Bio-Equivalence Studies by various Drug Control/Regulatory agencies  
like USFDA, Canadian FDA, MCA UK and other similar agencies.  
What are the specific generics or groups which require such a  
pre-requisite of Bio-Equivalence studies before being considered for  
granting registration/permission to market?

Are there any WHO guidelines available on the subject?

Naziruddin Ahsan  
Secretary  
Pharmacy Council of Pakistan  
Islamabad, Pakistan.  
ahsan@pharmacy.isb.sdnpk.org

--  
To send a message to E-Drug, write to: e-drug@usa.healthnet.org  
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org  
in the body of the message type: subscribe e-drug OR unsubscribe e-drug  
To contact a person, send a message to: e-drug-help@usa.healthnet.org  
Information and archives: [http://www.essentialdrugs.org/edrug](http://www.essentialdrugs.org/edrug)
